Jane Fang, MD, MS

Head of R&D Information for Clinical Biologics
AstraZeneca/MedImmune

Articles by Jane Fang, MD, MS

  • Rolling Feasibility in Competitive Immuno-Oncology Trials

    Tuesday, March 20, 2018
    Immuno-oncology (IO) is a fast-growing field at the frontier of cancer therapy. Data from ClinicalTrials.gov indicates a fiercely competitive landscape with over 47,000 oncology trials globally and nearly 1,000 IO studies. Many IO studies are ...
  • <<
  • >>